ATE227282T1 - 2,4-diaminopyrimidin-derivate - Google Patents

2,4-diaminopyrimidin-derivate

Info

Publication number
ATE227282T1
ATE227282T1 AT97923018T AT97923018T ATE227282T1 AT E227282 T1 ATE227282 T1 AT E227282T1 AT 97923018 T AT97923018 T AT 97923018T AT 97923018 T AT97923018 T AT 97923018T AT E227282 T1 ATE227282 T1 AT E227282T1
Authority
AT
Austria
Prior art keywords
diaminopyrimidine derivatives
diaminopyrimidine
derivatives
Prior art date
Application number
AT97923018T
Other languages
English (en)
Inventor
Philippe Guerry
Henri Stalder
Pierre-Charles Wyss
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Application granted granted Critical
Publication of ATE227282T1 publication Critical patent/ATE227282T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT97923018T 1996-05-15 1997-05-07 2,4-diaminopyrimidin-derivate ATE227282T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96107739 1996-05-15
PCT/EP1997/002355 WO1997043277A1 (en) 1996-05-15 1997-05-07 2,4-diaminopyrimidine derivatives

Publications (1)

Publication Number Publication Date
ATE227282T1 true ATE227282T1 (de) 2002-11-15

Family

ID=8222784

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97923018T ATE227282T1 (de) 1996-05-15 1997-05-07 2,4-diaminopyrimidin-derivate

Country Status (29)

Country Link
US (1) US5866583A (de)
EP (1) EP0901488B1 (de)
JP (1) JP3098259B2 (de)
KR (1) KR100295509B1 (de)
CN (1) CN1098260C (de)
AR (1) AR007088A1 (de)
AT (1) ATE227282T1 (de)
AU (1) AU726416B2 (de)
BR (1) BR9709251A (de)
CA (1) CA2254117C (de)
CO (1) CO4840509A1 (de)
CY (1) CY2425B1 (de)
CZ (1) CZ364698A3 (de)
DE (1) DE69716901T2 (de)
DK (1) DK0901488T3 (de)
ES (1) ES2184089T3 (de)
HR (1) HRP970260A2 (de)
IL (1) IL126702A0 (de)
MA (1) MA24182A1 (de)
NO (1) NO985335L (de)
NZ (1) NZ332481A (de)
PE (1) PE78898A1 (de)
PL (1) PL330277A1 (de)
PT (1) PT901488E (de)
TR (1) TR199802331T2 (de)
TW (1) TW438796B (de)
WO (1) WO1997043277A1 (de)
YU (1) YU51498A (de)
ZA (1) ZA973984B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998039328A1 (de) * 1997-03-03 1998-09-11 F.Hoffmann-La Roche Ag Substituted 2,4-diaminopyrimidines
JP4174077B2 (ja) * 1997-03-03 2008-10-29 バジリア ファルマスーチカ アーゲー 置換2,4−ジアミノピリミジン
US6277860B1 (en) * 1999-10-29 2001-08-21 Pfizer Inc Furopyridine antibacterials
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
WO2005011677A1 (en) * 2003-06-13 2005-02-10 Arena Pharmaceuticals, Inc. 5-substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor rup25 for the treatment of dyslipidemia and related diseases
US7659408B2 (en) * 2003-08-07 2010-02-09 Merck Sharp & Dhome Corp. Pyrazole carboxamides as inhibitors of 11-β-hydroxysteroid dehydrogenase-1
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
DE102005062987A1 (de) * 2005-12-28 2007-07-05 Grünenthal GmbH Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln
KR101167773B1 (ko) * 2007-08-03 2012-07-24 에프. 호프만-라 로슈 아게 Taar1 리간드로서의 피리딘카복스아마이드 및 벤즈아마이드 유도체
JP5621148B2 (ja) * 2008-11-21 2014-11-05 ラクオリア創薬株式会社 5−ht2b受容体拮抗活性を有する新規ピラゾール−3−カルボキサミド誘導体
EP2389376A1 (de) * 2009-01-21 2011-11-30 Basilea Pharmaceutica AG Neue bicyclische antibiotika
BR112012014683B1 (pt) * 2009-12-15 2017-11-07 Bayer Cropscience Ag Process for the production of 5-pyrazolcarboxylic acid derivatives 1-alkyl- / 1-aryl-substituted and compound acid
CA2832291C (en) 2011-04-05 2015-12-01 Pfizer Limited Pyrrolo[2,3-d)pyrimidine tropomyosin-related kinase inhibitors
DE102013208484B4 (de) 2013-05-08 2018-04-26 Wirtgen Gmbh Vorrichtung zum Bearbeiten von Straßen- oder Bodenoberflächen, sowie Verfahren zum Lenken einer Straßenfräsmaschine
US12043601B2 (en) * 2018-08-22 2024-07-23 The Regents Of The University Of Colorado N-substituted-1H-1,2,4-triazole-3-carboxamides, analogues thereof, and methods of treatment using same
AR117169A1 (es) * 2018-11-28 2021-07-14 Bayer Ag (tio)amidas de piridazina como compuestos fungicidas

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
US4013644A (en) * 1976-03-15 1977-03-22 G. D. Searle & Co. [8 α(E), 13aβ]-5,8,13,13a-tetrahydro-2,3,10,11-tetramethoxy-8-(2-phenylethenyl)-6H-dibenzo[a,g]quinolizines and intermediates thereto
NO811630L (no) * 1980-05-29 1981-11-30 Bayer Ag Imidazoazolalkensyreamider, nye mellomprodukter for deres fremstilling, deres fremstilling og deres anvendelse som legemiddel
US4594199A (en) * 1983-09-19 1986-06-10 E. R. Squibb & Sons, Inc. Method for making phosphinic acid intermediates
CA2095518A1 (en) * 1990-11-14 1992-05-15 Jeffrey M. Blaney Specific inhibition of dihydrofolate reductase and compounds therefor
CA2205406C (en) * 1994-11-24 2008-02-05 F. Hoffmann-La Roche Ag Novel benzyl pyrimidines
WO1996040640A1 (en) * 1995-06-07 1996-12-19 Pfizer Inc. BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION
DK0866791T3 (da) * 1995-12-04 2002-04-22 Arpida Ag Diaminopyrimidiner, farmaceutiske præparater indeholdende disse og deres anvendelse som antibakterielle midler

Also Published As

Publication number Publication date
DE69716901D1 (de) 2002-12-12
WO1997043277A1 (en) 1997-11-20
HRP970260A2 (en) 1998-04-30
JPH11511749A (ja) 1999-10-12
MA24182A1 (fr) 1997-12-31
YU51498A (en) 1999-11-22
KR100295509B1 (ko) 2001-09-17
CY2425B1 (en) 2004-11-12
AR007088A1 (es) 1999-10-13
DK0901488T3 (da) 2003-03-03
AU2894297A (en) 1997-12-05
DE69716901T2 (de) 2003-09-18
CN1218465A (zh) 1999-06-02
ES2184089T3 (es) 2003-04-01
CO4840509A1 (es) 1999-09-27
CZ364698A3 (cs) 1999-02-17
PL330277A1 (en) 1999-05-10
JP3098259B2 (ja) 2000-10-16
PE78898A1 (es) 1998-11-13
CA2254117C (en) 2003-03-11
CN1098260C (zh) 2003-01-08
PT901488E (pt) 2003-03-31
CA2254117A1 (en) 1997-11-20
ZA973984B (en) 1997-11-17
BR9709251A (pt) 1999-08-10
TR199802331T2 (xx) 1999-04-21
EP0901488B1 (de) 2002-11-06
AU726416B2 (en) 2000-11-09
US5866583A (en) 1999-02-02
KR20000011053A (ko) 2000-02-25
NO985335D0 (no) 1998-11-16
NO985335L (no) 1999-01-15
NZ332481A (en) 2000-04-28
EP0901488A1 (de) 1999-03-17
IL126702A0 (en) 1999-08-17
TW438796B (en) 2001-06-07

Similar Documents

Publication Publication Date Title
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
NL300150I2 (nl) 4 "-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
PT901474E (pt) Derivados de aril-pirimidina.
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
ATE227282T1 (de) 2,4-diaminopyrimidin-derivate
DK0922050T3 (da) 3-Descladinose-2,3-anhydroerythromycin-derivater
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
EE200000447A (et) 1,3,4-oksadiasolooni derivaadid
DE69714358D1 (de) 9,10-disubstituierte campothecinderivate mit antitumoraktivität
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
TR28915A (tr) Naftokinon türevleri.
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
ATE199901T1 (de) 10,11-dihydro-10-oxo-5h-dibenz(b,f)azepin-5- carboxamidderivate
DE69815072D1 (de) Substituierte 2,4-diaminopyrimidine
BR9708948A (pt) 1,3 - Benzodioxois substituídos
TR199700927A3 (tr) N-Benzilazolyum türevleri.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0901488

Country of ref document: EP

REN Ceased due to non-payment of the annual fee